JPRN-jRCT2080222208未知1 期
A dose escalation, single and multiple dose, Phase 1/2 study of KHK7580 for secondary hyperparathyroidism in patients receiving hemodialysis
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2013年9月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Written informed consent
- •- Stable chronic renal disease patients receiving hemodialysis 3 times weekly for at least 12 weeks prior to the screening
- •- intact PTH value of 240 pg/mL or more at the screening
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A PHASE 1, SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND SINGLE DOSE FOOD EFFECT STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF LND101001 IN HEALTHY MALE AND FEMALE SUBJECTS10042258Alzheimer's diseasedementiaNL-OMON37192upin Ltd74
已完成
不适用
Evaluation of biomarkers for JAK inhibitorKCT0005706Seoul National University Hospital8
已完成
1 期
A Phase I Single-Ascending Dose and Multiple-Ascending Dose Study of RO6889450 in Healthy Japanese MaleHealthy adultsJPRN-jRCT2080224516Chugai Pharmaceutical Co., Ltd.64
进行中（未招募）
1 期
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa using AAV8X-Linked retinitis pigmentosa (XLRP)MedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-003852-60-GBightstaRx Limited63
进行中（未招募）
1 期
A Sequential Phase I/II Dose Escalation and Dose Selection Safety Study of Regional Intra-thrombus Plasmin (Human) Infusion In Acute Lower Extremity Native Artery or Bypass Graft Occlusion - PRIORITYAcute Lower Extremity Native Artery or Bypass Graft OcclusionMedDRA version: 8.1Level: LLTClassification code 10043628Term: Thrombosis NOSEUCTR2006-002447-81-BGTalecris Biotherapeutics, Inc242